Leukemia immunotherapy: Overview of types, achievement rates, and additional details
Leukemia, a type of cancer that affects the body's blood and bone marrow, can be treated with a variety of methods. One of the promising approaches is immunotherapy, which uses certain medications to help the immune system fight the condition.
Immunotherapy vs. Chemotherapy
Compared to chemotherapy, immunotherapy offers a more targeted approach, reducing harm to healthy tissues. While chemotherapy is more systemic and affects many normal cells, causing broad and often severe side effects that limit dosing, immunotherapy specifically recognises and kills leukemia cells.
Success Rates
Immunotherapy has shown significant improvements in success rates for certain leukemia types. For instance, it has improved outcomes in relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL), showing higher rates of deep measurable residual disease negativity (meaning better disease eradication) and improved survival compared to chemotherapy alone. CAR T-cell therapy, a form of immunotherapy, has been especially effective against acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL), leading to durable remissions even in difficult cases.
Types of Leukemia Treated
Immunotherapy has shown notable success in treating B-ALL, including both Philadelphia chromosome-positive and -negative subtypes. CAR T-cell therapies are effective mainly for ALL and CLL. New immunotherapy strategies are emerging for acute myeloid leukemia (AML) by targeting leukemia stem cells and the tumor microenvironment, which may broaden the range of treatable leukemias.
Side Effects
Immunotherapy, including agents like blinatumomab and inotuzumab ozogamicin, tends to cause fewer and less severe side effects than chemotherapy because it targets specific leukemia cell markers, sparing most normal cells. New immunotherapies targeting leukemia stem cells have shown in preclinical models to eliminate cancer cells effectively without "major side effects," suggesting better tolerability than traditional chemotherapy.
Other Treatment Options
Other treatment options for leukemia include chemotherapy, radiation, medications to slow the growth of cancer cells, stem cell transplants, and supportive care such as antinausea drugs and antibiotics. Immunotherapy can be used alongside other treatments or after other treatments are complete.
Caution and Clinical Trials
It is crucial to discuss the risks and benefits of treatment with a doctor, ask about available clinical trials, and speak with an oncologist about one's treatment goals. This is especially important when considering immunotherapy, as side effects can include cytokine release syndrome, nausea, headache, vomiting, diarrhea, fever, chills, fainting, confusion, seizures, shaking or twitching, loss of balance, rash or blistering of the skin, and more.
Vaccines and the Future of Immunotherapy
Vaccines for leukemia are not yet widely available, but clinical trials have shown promise. As research continues, immunotherapy may transform standard treatment paradigms for leukemia, offering hope for those affected by this disease.
- Immunotherapy, a method that uses certain medications to help the immune system fight conditions like leukemia, offers a more targeted approach compared to chemotherapy, reducing harm to healthy tissues.
- Immunotherapy has shown significant improvements in success rates for certain types of leukemia, such as B-cell acute lymphoblastic leukemia (B-ALL), leading to better disease eradication and improved survival compared to chemotherapy alone.
- New immunotherapy strategies are emerging for acute myeloid leukemia (AML), which may broaden the range of treatable leukemias in the future.
- Immunotherapy tends to cause fewer and less severe side effects than chemotherapy because it targets specific leukemia cell markers, sparing most normal cells.
- As research continues, vaccines for leukemia may become available, transforming standard treatment paradigms for this medical condition and offering hope for those affected by leukemia.
